We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > coeliac disease

News List

Takeda acquires PvP Biologics following coeliac disease drug trial europeanpharmaceuticalreview
March 03, 2020
A statement by the Takeda reveals the company has acquired PvP as part of a development and option agreement for the drug TAK-062.
First Rare Disease Collaborative Network for refractory coeliac disease pharmatimes
November 22, 2018
Refractory coeliac disease, a deadly form of the autoimmune condition coeliac disease, has received its first dedicated support from NHS England, with the setting up of a Rare
Coeliac UK launches new research fund and appeal pharmatimes
July 23, 2018
Coeliac UK has launched a new research fund and fundraising appeal that aims to raise £5 million to improve understanding and management of coeliac disease and gluten related autoimmune conditions.
Experimental drug eases effects of gluten for coeliac patients on gluten-free diet europeanpharmaceuticalreview
May 29, 2018
First proof-of-concept study shows AMG 714 (anti-IL-15 monoclonal antibody) potentially protects celiac patients from inadvertent gluten exposure